Takayoshi Yoshikawa
- Post-marketing surveillance of pirfenidone for idiopathic pulmonary fibrosis in Japan: Interim analysis of 973 patientsBy Maki Ito, Yuka Niimi, Akihiro Nakamura, Shinichi Kakutani, Yuki Yoshida, Takayoshi Yoshikawa and Pirespa Advisory BoardMaki Ito1Drug Safety Management Department, Shionogi & Co., Ltd., Osaka, JapanYuka Niimi1Drug Safety Management Department, Shionogi & Co., Ltd., Osaka, JapanAkihiro Nakamura1Drug Safety Management Department, Shionogi & Co., Ltd., Osaka, JapanShinichi Kakutani2Biostatistics Department, Shionogi & Co., Ltd., Osaka, JapanYuki Yoshida2Biostatistics Department, Shionogi & Co., Ltd., Osaka, JapanTakayoshi Yoshikawa1Drug Safety Management Department, Shionogi & Co., Ltd., Osaka, Japan1Drug Safety Management Department, Shionogi & Co., Ltd., Osaka, Japan
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.